Deciphering the Biology of Circulating Tumor Cells through Single-Cell RNA Sequencing: Implications for Precision Medicine in Cancer
- PMID: 37569711
- PMCID: PMC10418766
- DOI: 10.3390/ijms241512337
Deciphering the Biology of Circulating Tumor Cells through Single-Cell RNA Sequencing: Implications for Precision Medicine in Cancer
Abstract
Circulating tumor cells (CTCs) hold unique biological characteristics that directly involve them in hematogenous dissemination. Studying CTCs systematically is technically challenging due to their extreme rarity and heterogeneity and the lack of specific markers to specify metastasis-initiating CTCs. With cutting-edge technology, single-cell RNA sequencing (scRNA-seq) provides insights into the biology of metastatic processes driven by CTCs. Transcriptomics analysis of single CTCs can decipher tumor heterogeneity and phenotypic plasticity for exploring promising novel therapeutic targets. The integrated approach provides a perspective on the mechanisms underlying tumor development and interrogates CTCs interactions with other blood cell types, particularly those of the immune system. This review aims to comprehensively describe the current study on CTC transcriptomic analysis through scRNA-seq technology. We emphasize the workflow for scRNA-seq analysis of CTCs, including enrichment, single cell isolation, and bioinformatic tools applied for this purpose. Furthermore, we elucidated the translational knowledge from the transcriptomic profile of individual CTCs and the biology of cancer metastasis for developing effective therapeutics through targeting key pathways in CTCs.
Keywords: circulating tumor cells; drug resistance; metastasis; personalized and precision medicine; single-cell RNA and transcriptome sequencing; tumor heterogeneity.
Conflict of interest statement
The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.
Figures


Similar articles
-
Hydro-Seq enables contamination-free high-throughput single-cell RNA-sequencing for circulating tumor cells.Nat Commun. 2019 May 15;10(1):2163. doi: 10.1038/s41467-019-10122-2. Nat Commun. 2019. PMID: 31092822 Free PMC article.
-
Mutational analysis of single circulating tumor cells by next generation sequencing in metastatic breast cancer.Oncotarget. 2016 May 3;7(18):26107-19. doi: 10.18632/oncotarget.8431. Oncotarget. 2016. PMID: 27034166 Free PMC article.
-
Cell Heterogeneity Analysis in Single-Cell RNA-seq Data Using Mixture Exponential Graph and Markov Random Field Model.Biomed Res Int. 2021 May 22;2021:9919080. doi: 10.1155/2021/9919080. eCollection 2021. Biomed Res Int. 2021. PMID: 34095314 Free PMC article.
-
Advances in the Characterization of Circulating Tumor Cells in Metastatic Breast Cancer: Single Cell Analyses and Interactions, and Patient-Derived Models for Drug Testing.Adv Exp Med Biol. 2020;1220:61-80. doi: 10.1007/978-3-030-35805-1_5. Adv Exp Med Biol. 2020. PMID: 32304080 Review.
-
Pancreatic cancer circulating tumor cells: applications for personalized oncology.Expert Rev Mol Diagn. 2018 Sep;18(9):809-820. doi: 10.1080/14737159.2018.1511429. Epub 2018 Aug 22. Expert Rev Mol Diagn. 2018. PMID: 30099926 Review.
Cited by
-
Progress of single-cell RNA sequencing combined with spatial transcriptomics in tumour microenvironment and treatment of pancreatic cancer.J Transl Med. 2024 Jun 12;22(1):563. doi: 10.1186/s12967-024-05307-3. J Transl Med. 2024. PMID: 38867230 Free PMC article. Review.
-
Enhancing detection and monitoring of circulating tumor cells: Integrative approaches in liquid biopsy advances.J Liq Biopsy. 2025 Apr 29;8:100297. doi: 10.1016/j.jlb.2025.100297. eCollection 2025 Jun. J Liq Biopsy. 2025. PMID: 40453103 Free PMC article. Review.
-
Circulating Nucleic Acids in Colorectal Cancer: Diagnostic and Prognostic Value.Dis Markers. 2024 Feb 13;2024:9943412. doi: 10.1155/2024/9943412. eCollection 2024. Dis Markers. 2024. PMID: 38380073 Free PMC article. Review.
-
Circulating Tumor Cells as Predictive and Prognostic Biomarkers in Solid Tumors.Cells. 2023 Nov 8;12(22):2590. doi: 10.3390/cells12222590. Cells. 2023. PMID: 37998325 Free PMC article. Review.
-
Exploring the Immunological Profile in Breast Cancer: Recent Advances in Diagnosis and Prognosis through Circulating Tumor Cells.Int J Mol Sci. 2024 Apr 29;25(9):4832. doi: 10.3390/ijms25094832. Int J Mol Sci. 2024. PMID: 38732051 Free PMC article. Review.
References
-
- Lowes L.E., Allan A.L. Chapter Four—Circulating Tumor Cells and Implications of the Epithelial-to-Mesenchymal Transition. In: Makowski G.S., editor. Advances in Clinical Chemistry. Volume 83. Elsevier; Amsterdam, The Netherlands: 2018. pp. 121–181. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources